Attachment25- QA Original RFP.pdf
PDF 164 KB Posted
- Attached to
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Solicitation number
- 75N95025R00005
About this file
This is a Questions and Answers document providing clarifications for a solicitation related to Chemistry, Manufacturing and Controls services for drug products issued by the National Center for Advancing Translational Sciences (NCATS).
Key clarifications include: The sample Task Order RFPs (TORFPs) are for evaluation purposes only and will not result in actual awards; offerors do not need to bid on all three technical areas and can propose on just one area without disadvantage; analytical methods must be qualified for cGMP material testing but not for Engineering Runs; offerors should assume they need to generate Master and Working Cell Banks and plasmids based on government-provided sequences; private companies must still provide salary information in their Total Compensation Plan; NCATS does not sign NDAs with vendors; and completion of the cost breakdown Excel spreadsheet (Attachment 14) is critical for evaluation purposes. The document also clarifies that subcontracting arrangements are acceptable when an offeror cannot fulfill all requirements internally, but specific tasks for subcontractors must be clearly identified.
View the file
Other files
Show all 27
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Questions and Answers/Clarifications
Q1. Given the specifics provided in the Sample Task Orders, they appear to be anticipated future procurements rather than “sample” TOs primarily provided for evaluation of the offeror’s proposal. Can the Government confirm if these TOs will be awarded after award of the master IDIQ contracts? This knowledge would impact the specifics of what information we might request from potential subcontractors.
A1. These are sample Task Order Requests for Proposals (TORFPs) only and WILL NOT result in actual task order awards. The responses to the sample TORFPs are used to assess the Offeror’s understanding of the types of requirements that the Government might have in future task orders, and the overall soundness, feasibility and completeness of the proposed approach to achieve the stated requirements.
Q2. Although a clear target of vg content has been specified for, are there any other specific expectations / acceptance criteria with regards to the final product e.g., Full / Empty viral particles ratio or other critical quality attributes?
A2. Offerors should address all requirements stated by the Government in their technical response to the sample TORFP. The Offeror may include in their response any additional critical quality attributes not otherwise specified by the Government that they deem relevant when describing their technical approach.
Q3. Regarding plasmid supply: will NCATS provide a sample of plasmid with GOI / REP-Cap9 / Helper or theoretical sequences? This would lead us to work with different partners/vendors for plasmid supply.
A3. The specific requirements of any future issued task orders may vary. In some cases, the Government may supply plasmids, while in other cases the Government may only be able to provide sequences. For the purposes of the response to the sample TORFP, Offerors should assume that they will need to generate the plasmids based upon sequences provided by the Government, and that the Government will not supply plasmid samples.
The intent of this RFP is to receive proposals from Offerors that fulfill the comprehensive range of requirements detailed within each Technical Area proposed upon. In cases where an Offeror may not be able to fulfill all requirements using purely internal resources, it is acceptable to propose partnering / subcontracting arrangements that would enable the Offeror to complement their own internal expertise and capabilities to provide that comprehensive support. Per the Additional Technical Proposal Instructions (See Attachment 7-Additional Technical Proposal Instructions_5.9.23), “Offerors proposing Subcontracts to perform portions of the Statement of Work should clearly identify the specific tasks for which they plan to utilize
Attachment 25 subcontractors, as well as the method and level of integration/coordination between the prime Contractor and all proposed Subcontractors, and the expected advantages of such an approach.”
Q4. Is the expectation that analytical methods are qualified for Engineering Run material testing and release?
A4. The analytical methods do not need to be qualified for the Engineering Run, but they must be qualified for testing and release of cGMP material.
Q5. Will a Master Cell Bank or Working Cell Bank be provided for development and cGMP manufacture – or should that be generated as part of this Task Order?
A5. For the purposes of the response to the sample TORFP, Offerors should assume that they will need to generate the Master and Working Cell Banks, and that the Government will not supply them.
Q6. Must an applicant submit a proposal applying for all of the items in the attachments? I s it possible to submit a proposal for just some of the Technical Areas?
A6. It is not necessary to bid on all three technical areas. It is entirely acceptable to propose on only one technical area, and that does not put an offeror at a disadvantage. Our expectation is that many vendors specialize in only one or two areas at the most. Each technical area proposed upon is scored on its own merits. We expect to make multiple awards within each technical area so that the Government has a roster of qualified vendors to serve the needs of each technical area. See Attachment 7-Additional Technical Proposal Instructions_Template_5.26.23_FINAL_, and Attachment 12- Additional_Business_Proposal_Instructions_Template_5.11.23_MC for additional guidance.
Q7. On the instructions for the Business Proposal, Subsection 3C under “Total Compensation Plan”. Our company is a private, for-profit organization and does not typically share salary information of our employees. Does this section still apply to a commercial company?
A7. Yes, this section applies to commercial companies.
Q8. In order to be able to submit our confidential pricing and methods for the package, we need to have an NDA in place.
A8. The National Center for Advancing Translational Sciences (NCATS) does not sign Non-Disclosure Agreements with vendors. Safeguarding proposal information and source selection information is safeguarded by FAR 3.104, Procurement integrity.
Q9. Do I need to complete the Excel spreadsheet?
A9. Yes, it is critical to complete Attachment 14_ Breakdown_of_Proposed_Estimated_Costs(plusfee)(5.19.23) for cost evaluation purposes.
File details come from the government source that posted it. Updated .